SOURCE: World Street Fundamentals

October 07, 2011 09:00 ET

Analyst View, Impact of Global Events - Research Report on Metabolix, Inc. and Lexicon Pharmaceuticals, Inc.

HONG KONG--(Marketwire - Oct 7, 2011) - Today, released its industry report highlighting Metabolix, Inc. (NASDAQ: MBLX) and Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX). Full fundamental and technical analysis is available at

Short-term outlooks within US and global economies continue to adjust downward, as US Treasury yields touched their lowest levels in over 65 years. International Monetary Fund downgraded estimates for US growth by 1.0% this year, down from 2.5%. 'Significant downside risks' to the US economy were confirmed by the Federal Reserve pressured by 'strains in global financial markets.'

As the US dollar trades above an eight-month high against the Euro, it highlights a deepening of the Eurozone sovereign debt crisis -- furthered by continued policy inaction from European governments. We expect continued volatility until economic data stabilizes and we see decisive policy action to deal with the Eurozone debt crisis.

Our members are preparing for a turn in tides. Currently, the Credit Suisse Risk Appetite Indicator is at a 30-year low. For the past three occurrences, this level has acted as a leading indicator of large stock market rallies 18 months following.

World Street Fundamentals has highlighted Metabolix, Inc. for its current position within the basic materials industry. Metabolix, Inc. is a bioscience company that develops and is in the process of commercializing environmentally sustainable, alternatives to petroleum-based plastics with chemicals and energy. The Company has core capabilities in microbial genetics, fermentation process engineering, chemical engineering, polymer science, plant genetics and botanical science. The entire report on Metabolix, Inc. (NASDAQ: MBLX) is available here:

World Street has featured Lexicon Pharmaceuticals, Inc. for its development within the healthcare industry. Lexicon Pharmaceuticals, Inc. (Lexicon) is a biopharmaceutical company focused on the discovery and development of treatments for human disease. The entire report on Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) is available here:

About World Street
World Street Fundamentals is an online portal for professionals, investors and new-comers to the markets to find in depth comprehensive research and research tools to help guide you through the ever changing financial markets.

Contact Information